Paul Nghiem, MD, PhD, discusses individualized therapies and the evolving role of AI in improving outcomes for actinic keratosis and related skin conditions.

Breast cancer survivors face increased skin cancer risk, necessitating regular dermatological check-ups and self-examinations ...

Please provide your email address to receive an email when new articles are posted on . Patients and clinicians agreed overall skin appearance and texture were improved with tirbanibulin treatment.

Sun Pharmaceutical Industries Limited ((IN:SUNPHARMA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Newly published ...

Credit: Almirall. The expanded approval was based on data from a phase 3 safety study which evaluated tirbanibulin in more than 100 adult patients with actinic keratosis. Findings showed the safety ...

Pharmacology: The mechanism of action by which ingenol mebutate induces cell death in treating actinic keratosis lesions is unknown. Clinical trials: In two double-blind, vehicle-controlled, clinical ...

Treatment for seborrheic keratosis is usually unnecessary. However, a person may choose to treat it with cryotherapy, shave excision, laser therapy, topical medications, or electrodesiccation with or ...

EXTON, Pa., Dec. 15, 2020 /PRNewswire/ -- Almirall, S.A. (BME:ALM), a global biopharmaceutical company focused on skin health, announced today that Klisyri® (tirbanibulin) has been approved by the U.S ...

DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast- 2034′′ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as ...